Where do Microbot Medical's ratios come from?

Every ratio is computed from Microbot Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Microbot Medical MBOT Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Returns
Return on equity	-27.6%+4.8pp	-32.4%-0.6pp	-31.9%+37.9pp	-69.8%-3.3pp	-66.5%+218pp
Return on assets	-26.1%+3.9pp	-30%0.0pp	-30.1%+32.6pp	-62.7%-1.6pp	-61%+98.4pp
Return on invested capital	-33%+6.3pp	-39.3%-2.2pp	-37.1%+52.6pp	-89.6%-10.8pp	-78.9%+754pp
Liquidity
Current ratio	22.6×-0.7×	23.3×-4.2×	27.5×+15.5×	12.1×-4.1×	16.2×+13.8×
Quick ratio	21.9×-1.2×	23.2×-4.3×	27.5×+15.5×	12×-4.1×	16.1×+13.8×
Cash ratio	1.1×-0.1×	1.1×-1.2×	2.3×+0.8×	1.5×-0.2×	1.7×+0.4×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Interest coverage	-8.8×+2.7×	-11.5×+10.2×	-21.6×+8.3×	-29.9×+15.0×	-44.9×+19.0×
Per Share
Book value per share	$1.10-34.9%	$1.69+4.1%	$1.63+95.5%	$0.83-10.7%	$0.93+313%
Valuation
Market capitalization	$128.28M+36.1%	$134.32M-16.6%	$161.02M+72.9%	$93.13M+77.5%	$52.46M+177%
Enterprise value	$125.53M+39.0%	$131.27M-15.4%	$155.17M+74.1%	$89.15M+80.5%	$49.39M+209%
Price / book	1.7×-1.4×	1.7×-0.3×	2.1×-1.0×	3.1×+1.3×	1.8×-3.6×
Free cash flow yield	-12%-1.5pp	-9.8%-2.9pp	-6.8%+3.8pp	-10.7%+7.1pp	-17.7%+28.9pp
Earnings yield	-11.1%+2.4pp	-9.8%-1.7pp	-8.1%+5.5pp	-13.6%+8.6pp	-22.2%+38.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Microbot Medical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Microbot Medical's ratios come from?: Every ratio is computed from Microbot Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.